Table 5.
Fractional arteriovenous fistula flow change during the intermediate time interval (2 to 6 weeks after access creation), as a function of patient demographics, comorbidities, fistula configuration, and adipose mediator levels
| Demographics/comorbidities | Fractional flow change (mean ± SD) | P value |
|---|---|---|
| Fistula configuration | ||
| Radiocephalic (13) | 0.42 ± 0.71 | 0.22 |
| Brachiocephalic (48) | 0.12 ± 0.52 | |
| Basilic Transposition (34) | 0.28 ± 0.73 | |
| Gender | ||
| Male (67) | 0.24 ± 0.65 | 0.68 |
| Female (28) | 0.17 ± 0.60 | |
| Race | ||
| Non–African American (41) | 0.21 ± 0.71 | 0.68 |
| African American (53) | 0.22 ± 0.58 | |
| Diabetes | ||
| Yes (65) | 0.17 ± 0.55 | 0.37 |
| No (30) | 0.33 ± 0.78 | |
| History of atherosclerotic disease | ||
| Yes (34) | 0.11 ± 0.55 | 0.26 |
| No (61) | 0.28 ± 0.67 | |
| History of hyperlipidemia | ||
| Yes (57) | 0.15 ± 0.58 | 0.18 |
| No (38) | 0.32 ± 0.70 | |
| History of smoking | ||
| Yes (56) | 0.19 ± 0.72 | 0.19 |
| No (39) | 0.26 ± 0.50 | |
| Renal replacement therapy | ||
| Yes (58) | 0.24 ± 0.66 | 0.72 |
| No (37) | 0.18 ± 0.60 | |
| BMI | ||
| <18.5 (underweight, 3) | 0.93 ± 0.93 | 0.14 |
| ≥30 (obese, 45) | 0.10 ± 0.54 | |
| ≥18.5 and <30 (normal/overweight, 47) | 0.28 ± 0.67 | |
| Leptin | ||
| First quartile | 0.39 ± 0.79 | 0.15 |
| Fourth quartile | 0.07 ± 0.52 |
BMI, body mass index.
Numbers of patients are in parentheses.